Clorox (NYSE:CLX) Releases FY 2026 Earnings Guidance

Key Points

• Clorox has provided an update to its FY 2026 earnings guidance, projecting earnings per share between 5.950 and 6.30, which is below the consensus estimate of 6.715.
• The company recently declared a quarterly dividend increase to $1.24, representing an annualized yield of 4.0% and a payout ratio of 87.61%.
• Multiple analysts have downgraded their price targets for Clorox, with Barclays reducing it from $129.00 to $119.00 and Wells Fargo from $142.00 to $135.00.

Clorox (NYSE:CLX - Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 5.950-6.30 for the period, compared to the consensus earnings per share estimate of 6.715. The company issued revenue guidance of -.

Clorox Price Performance

Shares of CLX traded down $0.64 during trading hours on Thursday, reaching $125.55. 4,107,825 shares of the company's stock traded hands, compared to its average volume of 1,620,312. The company has a current ratio of 0.74, a quick ratio of 0.44 and a debt-to-equity ratio of 13.07. The firm's 50 day simple moving average is $126.34 and its 200-day simple moving average is $139.61. The stock has a market cap of $15.47 billion, a PE ratio of 22.54, a price-to-earnings-growth ratio of 3.38 and a beta of 0.51. Clorox has a 12 month low of $117.35 and a 12 month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating analysts' consensus estimates of $2.25 by $0.62. Clorox had a net margin of 9.89% and a return on equity of 324.23%. Equities analysts expect that Clorox will post 7.15 EPS for the current year.

Clorox Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Wednesday, August 13th will be paid a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, August 13th. This is an increase from Clorox's previous quarterly dividend of $1.22. This represents a $4.96 dividend on an annualized basis and a yield of 4.0%. Clorox's payout ratio is currently 87.61%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the stock. Barclays dropped their price target on shares of Clorox from $129.00 to $119.00 and set an "underweight" rating on the stock in a research note on Tuesday, July 15th. Wells Fargo & Company cut their price target on shares of Clorox from $142.00 to $135.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 9th. JPMorgan Chase & Co. decreased their price objective on shares of Clorox from $144.00 to $140.00 and set a "neutral" rating for the company in a report on Friday, July 25th. Jefferies Financial Group reduced their target price on Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a report on Thursday, June 26th. Finally, UBS Group lowered their price target on Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a report on Thursday, July 17th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $144.83.

Insider Buying and Selling at Clorox

In other news, Director Pierre R. Breber purchased 4,000 shares of the stock in a transaction dated Wednesday, May 7th. The shares were purchased at an average cost of $136.57 per share, with a total value of $546,280.00. Following the completion of the purchase, the director directly owned 4,000 shares of the company's stock, valued at approximately $546,280. The trade was a ∞ increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 0.57% of the company's stock.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Clorox stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in The Clorox Company (NYSE:CLX - Free Report) by 4.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,380 shares of the company's stock after acquiring an additional 514 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in Clorox were worth $1,970,000 as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.